Gene · 2176
Papers2,586
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 2,586
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances in the study of HSP70 inhibitors to enhance the sensitivity of tumor cells to radiotherapy. | Front Cell Dev Biol | 2022 | 36036010 | PubTator, text mining | PubMed |
| Identification and validation of a poor clinical outcome subtype of primary prostate cancer with Midkine abundance. | Cancer Sci | 2022 | 36018546 | PubTator, text mining | PubMed |
| Wnt/β-Catenin-Pathway Alterations and Homologous Recombination Deficiency in Cholangiocarcinoma Cell Lines and Clinical Samples: Towards Specific Vulnerabilities. | J Pers Med | 2022 | 36013219 | PubTator, text mining | PubMed |
| How Can Apartment-Complex Landscaping Space Improve Residents' Psychological Well-Being?: The Case of the Capital Region in South Korea. | Int J Environ Res Public Health | 2022 | 36011865 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Genomic Alterations in Hepatoid Adenocarcinoma of the Stomach and Identification of Clinically Actionable Alterations. | Cancers (Basel) | 2022 | 36010842 | PubTator, text mining | PubMed |
| Diversity of Phospholipases A2 from Bothrops atrox Snake Venom: Adaptive Advantages for Snakes Compromising Treatments for Snakebite Patients. | Toxins (Basel) | 2022 | 36006204 | PubTator, text mining | PubMed |
| Survival outcomes of patients with muscle-invasive bladder cancer according to pathological response at radical cystectomy with or without neo-adjuvant chemotherapy: a case-control matching study. | Int Urol Nephrol | 2022 | 35997906 | PubTator, text mining | PubMed |
| Quantitative Acoustophoresis. | ACS Nanosci Au | 2022 | 35996438 | PubTator, text mining | PubMed |
| Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer. | Nat Genet | 2022 | 35995947 | PubTator, text mining | PubMed |
| The potential effects and mechanisms of breast inflammatory lesions on the occurrence and development of breast cancer. | Front Oncol | 2022 | 35992864 | PubTator, text mining | PubMed |
| Case report: Mesothelioma and BAP1 tumor predisposition syndrome: Implications for public health. | Front Oncol | 2022 | 35992853 | PubTator, text mining | PubMed |
| Chromosomal instability in adult-type diffuse gliomas. | Acta Neuropathol Commun | 2022 | 35978439 | PubTator, text mining | PubMed |
| Chromothripsis is a frequent event and underlies typical genetic changes in early T-cell precursor lymphoblastic leukemia in adults. | Leukemia | 2022 | 35974102 | PubTator, text mining | PubMed |
| Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients. | Genome Med | 2022 | 35971132 | PubTator, text mining | PubMed |
| High Correlations Among Worldwide Prevalences of Dementias, Parkinson's Disease, Multiple Sclerosis, and Motor Neuron Diseases Indicate Common Causative Factors. | Neurosci Insights | 2022 | 35965966 | PubTator, text mining | PubMed |
| Ferroptosis in inflammatory arthritis: A promising future. | Front Immunol | 2022 | 35958605 | PubTator, text mining | PubMed |
| Correction of Fanconi Anemia Mutations Using Digital Genome Engineering. | Int J Mol Sci | 2022 | 35955545 | PubTator, text mining | PubMed |
| Mutated FANCA Gene Role in the Modulation of Energy Metabolism and Mitochondrial Dynamics in Head and Neck Squamous Cell Carcinoma. | Cells | 2022 | 35954197 | PubTator, text mining | PubMed |
| RAD54B mutations enhance the sensitivity of ovarian cancer cells to poly(ADP-ribose) polymerase (PARP) inhibitors. | J Biol Chem | 2022 | 35952757 | PubTator, text mining | PubMed |
| Evaluation of a Patient With Non-Myoinvasive Uterine Serous Carcinoma Confined to a Polyp and Positive Peritoneal Washings With Somatic ARHGAP35 and KRAS Mutations. | Cureus | 2022 | 35949786 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2176/papers?page=23